Global Health · NSE: MEDANTA · BSE: 543654
Q3 FY26 results · Oct–Dec 2025
Global Health reported revenue from operations of ₹1,121.05 crore (up 18.8% from Q3 FY25) and net profit of ₹95.03 crore (down 33.5% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,121.05 | 943.44 | +18.8% | 1,099.22 | +2.0% |
| Other income | 21.78 | 16.02 | +35.9% | 19.73 | +10.4% |
| Total income | 1,142.83 | 959.46 | +19.1% | 1,118.95 | +2.1% |
| Profit before tax | 119.78 | 189.07 | −36.6% | 199.81 | −40.1% |
| Net profit for the period | 95.03 | 142.86 | −33.5% | 158.40 | −40.0% |
| Attributable to shareholders of the company | 95.02 | 142.91 | −33.5% | 158.44 | −40.0% |
| EPS, basic (₹) | 3.54 | 5.32 | −33.5% | 5.89 | −39.9% |
| Net margin (%) | 8.5 | 15.1 | 14.4 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 940.16 | 624.40 | +50.6% | 926.43 | +1.5% |
| Other income | 24.66 | 22.17 | +11.3% | 22.80 | +8.2% |
| Total income | 964.83 | 646.57 | +49.2% | 949.23 | +1.6% |
| Profit before tax | 102.89 | 132.31 | −22.2% | 185.05 | −44.4% |
| Net profit for the period | 79.91 | 99.31 | −19.5% | 140.20 | −43.0% |
| EPS, basic (₹) | 2.97 | 3.70 | −19.7% | 5.22 | −43.1% |
| Net margin (%) | 8.5 | 15.9 | 15.1 |
Consolidated
- Filed with BSE
- 04 Feb 2026, 16:04 IST
- Board meeting
- 04 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Feb 2026, 16:04 IST
- Board meeting
- 04 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE